Vienna Biocenter

The Vienna BioCenter is a cluster of life science research institutes and biotechnology companies located in the 3rd municipal District of Vienna, Austria. It grew around the Research Institute of Molecular Pathology (IMP), which opened in 1988. The entities at the Vienna BioCenter employ more than 1,700 people, including 600 students.[1][2]

Vienna Biocenter Campus 5
Vienna Biocenter Campus 5
Vienna Biocenter Campus 3

Structure

As of 2017, the Vienna BioCenter is an association of 4 research institutes, 18 biotech companies, 2 outreach organisations, 3 service companies and a business incubator.

The four basic research institutes are the Research Institute of Molecular Pathology (IMP), the Max Perutz Labs of the University of Vienna and Medical University of Vienna, the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences (ÖAW), and the Gregor Mendel Institute of Molecular Plant Biology (GMI), also of the ÖAW.[3] These institutes maintain a joint international PhD programme.[4]

The "Vienna BioCenter Core Facilities" (VBCF) offer central services, largely scientific, but also including a child care centre.[5]

Awards

Kim Nasmyth, emeritus director of the Institute of Molecular Pathology, currently at the University of Oxford, received the 2018 Breakthrough Prize in Life Sciences for his work on chromosome segregation.[6][7]

As of May 2017, scientists of the Vienna BioCenter institutes have been awarded over 40 ERC grants and seven Wittgenstein Awards.[8]

References
  1. Austria, Regionalmedien (2017-07-07). "Biotechnologie: Die Zellversteher von Sankt Marx". meinbezirk.at (in German). Retrieved 2017-12-20.
  2. Tebb, Graham (2008). "Vienna landmark". Current Biology. Elsevier BV. 18 (12): R499–R500. doi:10.1016/j.cub.2008.06.009. ISSN 0960-9822.
  3. "Spotlight on Austria". Nature Jobs. Springer Nature. 2014-04-23. doi:10.1038/nj0422. ISSN 1476-4687.
  4. "PhD PROGRAMME". Vienna Biocenter PhD Programme. Retrieved 2017-12-20.
  5. "VBCF | Home". vbcf.ac.at. 2017-07-07. Retrieved 2017-07-12.
  6. "Kim Nasmyth: Glücklicher Held einer Wiener Erfolgsgeschichte". DER STANDARD (in German). 2018-02-10. Retrieved 2018-02-18.
  7. "Breakthrough Prize awarded to Kim Nasmyth". The Research Institute of Molecular Pathology. 2017-12-04. Retrieved 2018-02-18.
  8. Presse-Service (2017-05-03). "Archivmeldung: Angebot komplettiert: Erste Start-up Labs für Wiener Life Science-Branche". Presseservice der Stadt Wien (in German). Retrieved 2017-12-20.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.